A PACS Admin’s Life

One man takes on the world of PACS, RIS, dicom, and all that is digital imaging.

FDA warns Covidien about adulterated imaging agent at Missouri plant

The FDA has sent a warning letter to Covidien’s CEO and President
Richard J. Meelia, based on an inspection of its pharmaceutical
manufacturing operation Maryland Heights, Mo., that “revealed serious
deviations from the good manufacturing practice regulations.”

Bookmark to:
Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to Del.icio.us Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to digg Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to FURL Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to blinklist Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to My-Tuts Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to reddit Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to Feed Me Links! Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to Technorati Add 'FDA warns Covidien about adulterated imaging agent at Missouri plant' to Socializer 

Syndicate

Sponsership Centre

Activity

No comments, leave your comment or trackback.

Leave a Reply


Search

The archives run deep. Feel free to search older content using topic keywords.

  You're new! If you like it here, please subscribe to my feed.      
[Close]